HAMP and hydrops fetalis: These results align with the observed hepcidin-lowering effects of SGLT2i, supporting their potential to improve iron mobilization and utilization in patients with HF with ID by enhancing the release of iron from storage sites and facilitating its availability for erythropoiesis [83].